Q32 Bio Balance Sheet Health

Financial Health criteria checks 5/6

Q32 Bio has a total shareholder equity of $18.3M and total debt of $15.3M, which brings its debt-to-equity ratio to 83.5%. Its total assets and total liabilities are $104.5M and $86.2M respectively.

Key information

83.5%

Debt to equity ratio

US$15.28m

Debt

Interest coverage ration/a
CashUS$89.08m
EquityUS$18.30m
Total liabilitiesUS$86.25m
Total assetsUS$104.54m

Recent financial health updates

No updates

Recent updates

Q32 Bio: High-Risk, High-Reward With Bempikibart And ADX-097

Aug 29

Financial Position Analysis

Short Term Liabilities: QTTB's short term assets ($93.9M) exceed its short term liabilities ($14.4M).

Long Term Liabilities: QTTB's short term assets ($93.9M) exceed its long term liabilities ($71.9M).


Debt to Equity History and Analysis

Debt Level: QTTB has more cash than its total debt.

Reducing Debt: Insufficient data to determine if QTTB's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: QTTB has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: QTTB has sufficient cash runway for 1 years if free cash flow continues to reduce at historical rates of 25.9% each year.


Discover healthy companies